Ironwood Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ironwood Pharmaceuticals patents 30 in total
Status | Patent |
---|---|
Application | Utility: Stable Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: Modified or Targeted Release Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: Treatments for Gastrointestinal Disorders Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: Treatment of Constipation-Predominant Irritable Bowel Syndrome Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: Gastro-Retentive Sustained-Release Oral Dosage Form of a Bile Acid Sequestrant Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: Low-Dose Stable Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: Treatments for Gastrointestinal Disorders Filling date: 6 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: Gastro-Retentive Sustained-Release Oral Dosage Form of a Bile Acid Sequestrant Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: Method of Generating Anti-Linaclotide Antibodies and Uses Thereof Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: Treatments for Gastrointestinal Disorders Filling date: 6 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: GASTRO-RETENTIVE SUSTAINED-RELEASE ORAL DOSAGE FORM OF A BILE ACID SEQUESTRANT Filling date: 6 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: Treatments for Gastrointestinal Disorders Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Grant | Utility: Stable formulations of linaclotide Filling date: 6 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Utility: Stable formulations of linaclotide Filling date: 6 Sep 2025 Issue date: 9 Jun 2020 |
Application | Utility: Method of Generating Anti-Linaclotide Antibodies and Uses Thereof Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: Method of Detecting and Quantifying Bile Acid from Saliva Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Utility: Compositions for colon cleansing and the treatment of gastrointestinal disorders Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: Low-Dose Stable Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: Stable Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: Stable Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: Modified or Targeted Release Formulations of Linaclotide Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: SGC STIMULATORS Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Treatment of Constipation-Predominant Irritable Bowel Syndrome Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: PYRAZOLE DERIVATIES AS SGC STIMULATORS Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: SOLID DISPERSIONS COMPRISING A SGC STIMULATOR Filling date: 6 Sep 2025 Issue date: 5 Sep 2019 |
Showing 1 to 30 of 30 patents.